Priorin Extra Anti Hair Loss Treatment

Priorin capsules against hair loss - strengthens hair roots from within. Helps to increase hair growth

Priorin capsules use their micronutrients to provide hair roots with important basic building blocks. The growth is supported and the number of hairs in the growth phase is increased

More fullness, more strength, more hair

A study demonstrates the efficacy of priorin capsules. Women who treated their hair loss with Priorin capsules were able to notice a significant increase in hair growth after 3 months, compared to the placebo preparation. *

The Priorin Capsules Against Hair Loss strengthen your hair roots from within and help increase hair growth. The capsules supply hair cells the important micronutrients for more fullness, more strength and, of course, more hair. After 3-month, significant increase in hair was shown in research*. The special ingredients include millet extract, Vitamin B5 and Cystine.

Millet extract forms the basis of the Priorin Capsule and is obtained in a special procedure. Millet contains essential vitamins and minerals, but also natural silicon compounds.

The essential vitamin B5 plays a central role in the metabolism-active tissue. It is of particular importance for the natural cell regeneration processes.

The protein component of cystine is a natural component of the hair substance (keratin).

 

How to Use

In case of hair loss: In the first 3 months in the morning 2 capsules and in the evening 1 capsule with water. Then for sustained treatment, a dose of 1 capsule per day is usually sufficient.

For lighter hair growth disorders: Take 1 capsule Priorin once daily with water.

 

Ingredients

Millet extract, millet extract, millet extract 140 MG, calcium pantothenate, pantothenic acid 9 MG, L-cystine 2 MG, wheat germ oil, gelatin from beef, gelatin from pig, glycerol, sorbitol syrup, wax, yellow (3-sn-phosphatidyl) choline (soybean), magnesium oxide, iron oxides and hydroxides, titanium dioxide, aromatics, natural, natural-identical

*W. Gehring et al., Journal of Skin Diseases, H + G 7/8 (75) 419-423 (2000), n = 40.